| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
| Cadmium |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cadmium up-regulates the expression of DME IDS |
[1] |
| Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde inhibits the expression of DME IDS |
[2] |
| Sarin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00779
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Sarin inhibits the expression of DME IDS |
[3] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 up-regulates the expression of DME IDS |
[4], [5] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Lithium chloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01369
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health Hazard |
| DME Modulation |
Lithium chloride induces the drug-metabolizing activity of DME IDS |
[6] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 16 Xenobiotics
|
| Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide up-regulates the expression of DME IDS |
[7] |
| Carmustine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00012
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Carmustine inhibits the expression of DME IDS |
[8] |
| Cidofovir |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00132
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cidofovir inhibits the expression of DME IDS |
[9] |
| Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin inhibits the expression of DME IDS |
[9] |
| Copper sulfate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate up-regulates the expression of DME IDS |
[10] |
| Cyclosporine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine up-regulates the expression of DME IDS |
[11] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride up-regulates the expression of DME IDS |
[12] |
| Estradiol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol inhibits the expression of DME IDS |
[13] |
| Ibuprofen |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00248
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ibuprofen up-regulates the expression of DME IDS |
[9] |
| Ifosfamide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00046
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ifosfamide inhibits the expression of DME IDS |
[9] |
| Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Tretinoin inhibits the expression of DME IDS |
[14] |
| Urethane |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Urethane up-regulates the expression of DME IDS |
[15] |
| Valproic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Valproic acid up-regulates the expression of DME IDS |
[16] |
| Vorinostat |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00079
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Vorinostat inhibits the expression of DME IDS |
[17] |
| Clodronic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00465
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Clodronic acid inhibits the expression of DME IDS |
[9] |
| Demecolcine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00466
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Demecolcine up-regulates the expression of DME IDS |
[2] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Trichostatin A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01492
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Trichostatin A induces the drug-metabolizing activity of DME IDS |
[18] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Phenylmercuric acetate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00818
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Phenylmercuric acetate up-regulates the expression of DME IDS and leads to increasing the drug-metabolizing activity of this enzyme |
[19] |
|
|
|
|
|
|